China Resources Double-Crane Pharmaceutical Co Ltd (600062) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥487.90 Million ≈ $71.40 Million USD) by net assets (CN¥12.16 Billion ≈ $1.78 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600062 stock market capitalisation for the company's overall valuation and market capitalisation.

China Resources Double-Crane Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how China Resources Double-Crane Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

China Resources Double-Crane Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Double-Crane Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 600062 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ebos Group Ltd AU:EBO	0.017x
Zhuhai Bojay Electronics Co Ltd SHE:002975	0.010x
Zhejiang Orient Holdings Co Ltd SHG:600120	0.049x
Embotelladora Andina S.A SN:ANDINA-B	0.110x
Bausch Health Companies Inc TO:BHC	-0.835x
Hugo Boss AG F:BOSA	0.038x
BREVILLE GROUP LTD F:HDE	N/A
Fabege AB ST:FABG	0.023x

Annual Cash Flow Conversion Efficiency for China Resources Double-Crane Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Double-Crane Pharmaceutical Co Ltd from 1998 to 2024. View 600062 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.11 Billion ≈ $1.63 Billion	CN¥1.83 Billion ≈ $267.07 Million	0.164x	+17.31%
2023-12-31	CN¥11.79 Billion ≈ $1.73 Billion	CN¥1.65 Billion ≈ $241.56 Million	0.140x	+11.98%
2022-12-31	CN¥10.73 Billion ≈ $1.57 Billion	CN¥1.34 Billion ≈ $196.33 Million	0.125x	-2.30%
2021-12-31	CN¥10.48 Billion ≈ $1.53 Billion	CN¥1.34 Billion ≈ $196.22 Million	0.128x	-11.76%
2020-12-31	CN¥9.38 Billion ≈ $1.37 Billion	CN¥1.36 Billion ≈ $199.03 Million	0.145x	-12.59%
2019-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.44 Billion ≈ $210.69 Million	0.166x	-10.67%
2018-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.47 Billion ≈ $214.97 Million	0.186x	+22.81%
2017-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥1.19 Billion ≈ $173.71 Million	0.151x	+38.03%
2016-12-31	CN¥7.04 Billion ≈ $1.03 Billion	CN¥771.25 Million ≈ $112.86 Million	0.110x	+0.52%
2015-12-31	CN¥6.43 Billion ≈ $941.48 Million	CN¥701.35 Million ≈ $102.63 Million	0.109x	-13.74%
2014-12-31	CN¥5.68 Billion ≈ $831.80 Million	CN¥718.38 Million ≈ $105.12 Million	0.126x	+23.46%
2013-12-31	CN¥5.34 Billion ≈ $780.86 Million	CN¥546.24 Million ≈ $79.93 Million	0.102x	+21.65%
2012-12-31	CN¥4.71 Billion ≈ $688.74 Million	CN¥396.05 Million ≈ $57.95 Million	0.084x	-28.55%
2011-12-31	CN¥4.34 Billion ≈ $635.56 Million	CN¥511.53 Million ≈ $74.85 Million	0.118x	-9.28%
2010-12-31	CN¥3.93 Billion ≈ $574.49 Million	CN¥509.67 Million ≈ $74.58 Million	0.130x	+34.17%
2009-12-31	CN¥3.53 Billion ≈ $517.25 Million	CN¥342.01 Million ≈ $50.05 Million	0.097x	-8.10%
2008-12-31	CN¥3.15 Billion ≈ $461.01 Million	CN¥331.71 Million ≈ $48.54 Million	0.105x	+5.74%
2007-12-31	CN¥2.36 Billion ≈ $346.03 Million	CN¥235.46 Million ≈ $34.45 Million	0.100x	-34.59%
2006-12-31	CN¥2.00 Billion ≈ $291.96 Million	CN¥303.71 Million ≈ $44.44 Million	0.152x	+111.19%
2005-12-31	CN¥1.94 Billion ≈ $283.78 Million	CN¥139.78 Million ≈ $20.45 Million	0.072x	-72.56%
2004-12-31	CN¥1.73 Billion ≈ $252.76 Million	CN¥453.72 Million ≈ $66.39 Million	0.263x	+202.75%
2003-12-31	CN¥1.72 Billion ≈ $251.20 Million	CN¥148.94 Million ≈ $21.79 Million	0.087x	-0.99%
2002-12-31	CN¥1.60 Billion ≈ $234.85 Million	CN¥140.63 Million ≈ $20.58 Million	0.088x	-7.41%
2001-12-31	CN¥1.49 Billion ≈ $218.03 Million	CN¥141.01 Million ≈ $20.63 Million	0.095x	-53.16%
2000-12-31	CN¥855.27 Million ≈ $125.15 Million	CN¥172.81 Million ≈ $25.29 Million	0.202x	+9.25%
1999-12-31	CN¥711.23 Million ≈ $104.08 Million	CN¥131.54 Million ≈ $19.25 Million	0.185x	+826.55%
1998-12-31	CN¥541.45 Million ≈ $79.23 Million	CN¥-13.78 Million ≈ $-2.02 Million	-0.025x	--

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.45 Billion

CN¥16.76 Billion CNY

Market Cap Rank

#5571 Global

#1019 in China

Share Price

CN¥16.13

Change (1 day)

+0.69%

52-Week Range

CN¥15.60 - CN¥19.70

All Time High

CN¥33.06